Literature DB >> 21620836

PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity.

Christina Schülein1, Martin Eilers, Nikita Popov.   

Abstract

The Fbw7 tumor suppressor gene encodes the substrate recognition subunit of the SCF ubiquitin ligase, which targets for degradation a range of oncogenic proteins in a phosphorylation-dependent manner. Substrate phosphorylation is thought to be the main mechanism that ensures timely destruction of Fbw7 substrates. We show here that PI3K dependent phosphorylation of Fbw7 stimulates its ability to ubiquitinate and degrade its substrates. Mutation of the phosphorylation site destabilizes Fbw7 and attenuates degradation of cyclin E and Myc leading to the enhanced expression of a subset of Myc target genes. We suggest that PI3K-dependent phosphorylation of Fbw7 controls the balance between turnover of Fbw7 and its substrates to fine-tune their activity.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620836     DOI: 10.1016/j.febslet.2011.05.036

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Paracrine signaling through MYCN enhances tumor-vascular interactions in neuroblastoma.

Authors:  Yvan H Chanthery; W Clay Gustafson; Melissa Itsara; Anders Persson; Christopher S Hackett; Matt Grimmer; Elise Charron; Slava Yakovenko; Grace Kim; Katherine K Matthay; William A Weiss
Journal:  Sci Transl Med       Date:  2012-01-04       Impact factor: 17.956

2.  The pseudophosphatase STYX targets the F-box of FBXW7 and inhibits SCFFBXW7 function.

Authors:  Veronika Reiterer; Cristina Figueras-Puig; Francois Le Guerroue; Stefano Confalonieri; Manuela Vecchi; Dasaradha Jalapothu; Sandip M Kanse; Raymond J Deshaies; Pier Paolo Di Fiore; Christian Behrends; Hesso Farhan
Journal:  EMBO J       Date:  2016-12-22       Impact factor: 11.598

Review 3.  Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.

Authors:  Liangliang Xing; Leidi Xu; Yong Zhang; Yinggang Che; Min Wang; Yongxiang Shao; Dan Qiu; Honglian Yu; Feng Zhao; Jian Zhang
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

4.  FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.

Authors:  Rui Wang; Yan Wang; Ning Liu; Chunguang Ren; Cong Jiang; Kai Zhang; Su Yu; Yunfei Chen; Hui Tang; Qi Deng; Cong Fu; Yingcong Wang; Rong Li; Mingyao Liu; Weijun Pan; Ping Wang
Journal:  Cell Res       Date:  2013-03-19       Impact factor: 25.617

Review 5.  Physiological functions of FBW7 in cancer and metabolism.

Authors:  Kouhei Shimizu; Naoe Taira Nihira; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Cell Signal       Date:  2018-02-21       Impact factor: 4.315

Review 6.  The ubiquitin-proteasome system and signal transduction pathways regulating Epithelial Mesenchymal transition of cancer.

Authors:  Ioannis A Voutsadakis
Journal:  J Biomed Sci       Date:  2012-07-24       Impact factor: 8.410

7.  Fbw7 and Usp28 - enemies and allies.

Authors:  Lyudmyla Taranets; Jing Zhu; Wenshan Xu; Nikita Popov
Journal:  Mol Cell Oncol       Date:  2015-01-23

8.  Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- tumors.

Authors:  Matthias Lechner; Garrett M Frampton; Tim Fenton; Andrew Feber; Gary Palmer; Amrita Jay; Nischalan Pillay; Martin Forster; Maureen T Cronin; Doron Lipson; Vincent A Miller; Timothy A Brennan; Stephen Henderson; Francis Vaz; Paul O'Flynn; Nicholas Kalavrezos; Roman Yelensky; Stephan Beck; Philip J Stephens; Chris Boshoff
Journal:  Genome Med       Date:  2013-05-29       Impact factor: 11.117

Review 9.  Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis.

Authors:  Jun Cao; Ming-Hua Ge; Zhi-Qiang Ling
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

10.  The stability of Fbw7α in M-phase requires its phosphorylation by PKC.

Authors:  Sihem Zitouni; Francisca Méchali; Catherine Papin; Armelle Choquet; Daniel Roche; Véronique Baldin; Olivier Coux; Catherine Bonne-Andrea
Journal:  PLoS One       Date:  2017-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.